Clinical Trial Update: Controlled Study to Evaluate Efficacy and Safety of α-KA Tab With Low Protein Diet (LPD) in Delaying the Progress of Type 2 Diabetic Nephropathy (DN) [Phase 4]

View source ↗

Summary

This update reports the completion of a Phase 4 clinical trial evaluating the efficacy and safety of α-KA tablets with a low-protein diet to delay progression o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy

Drugs mentioned

• α-KA Tab

Snippet

Sponsor: Fresenius Kabi | Conditions: Diabetic Nephropathy | Phase 4 | Status: COMPLETED